Senate GOP considers deeper Medicaid cuts than House bill … The Senate is close to a healthcare bill, but do Republicans have the votes? … FDA approves MRSA drug … Cleveland Clinic receives...
Skilled nursing claims continue to be eclipsed by assisted living claims by average cost, CNA reports
By
Kathleen Steele Gaivin
Mar 18, 2022
The average cost of assisted living professional liability claims ($267,174) has outpaced such claims by skilled nursing facilities ($245,559) over the past few years, according to the 11th edition of...
Sleepiness, Alzheimer’s linked in study
By
Lois A. Bowers
Mar 13, 2018
Are your residents who do not have dementia excessively sleepy during the daytime? If so, then they may be at risk for an increased accumulation of a brain protein that is a biomarker for Alzheimer’s...
One in three Alzheimer’s, dementia cases tied to modifiable risk factors
May 11, 2022
Risk factors differ based on sex and race and ethnicity.
Vascular risk factors only explain part of Alzheimer’s disease risk for Blacks, Hispanics
Jan 11, 2023
Barriers to healthcare access and other socioeconomic factors may increase vulnerability in racial/ethnic minorities.
US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
Silent sentinels
By
Julie E. Williamson
May 11, 2017
Operators are adopting innovative, unobtrusive and increasingly silent security solutions that can be tailored to meet the needs of each resident in your community.
Moving more may help older adults maintain memory, study finds
By
Lois A. Bowers
Jan 18, 2019
Staying active in old age may help memory and thinking, according to a study published in Neurology, the medical journal of the American Academy of Neurology.
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
FDA approves first treatment for Alzheimer’s in 18 years
By
Kimberly Bonvissuto
Jun 07, 2021
The first novel therapy for Alzheimer’s disease in almost two decades was approved today by the Food & Drug Administration.